Literature DB >> 20422280

Modulation of synaptic transmission and analysis of neuroprotective effects of valproic Acid and derivates in rat embryonic motoneurons.

D Ragancokova1, Y Song, H Nau, R Dengler, K Krampfl, S Petri.   

Abstract

Amyotrophic lateral sclerosis is a devastating motoneuron disorder for which no effective treatment exists. There is some evidence for neuroprotective effects of valproic acid (VPA). The beneficial effects, however, are limited due to the adverse effects of VPA. To overcome this problem, a number of VPA derivates with fewer side effects have been synthesized. In the present study, we investigated the viability of highly purified embryonic motoneurons cultured on glial feeder layers, composed of either astrocytes or Schwann cells, or in monoculture, in presence of VPA and its three derivates 3-propyl-heptanoic acid (3-PHA), PE-4-yn enantiomers (R- and S-PE-4-yn). An excitotoxic stimulus, kainate (KA), was added at day in vitro 9 (DIV9) and the neuroprotective effect of either simultaneous incubation (DIV9) or pre-incubation (DIV1) of VPA and its derivates was tested. The survival of motoneurons under simultaneous application of KA and VPA derivates was not remarkably increased. Pre-incubation with VPA and even more with the derivates before the addition of KA, however, significantly reduced their vulnerability against the KA-induced neurotoxic effect. Our data suggest that the neuroprotective capacities of VPA and its three derivates tested here drastically increase when they are added several days before KA. Most prominent neuroprotective effects were seen for the PE-4-yn enantiomers. Patch-clamp experiments revealed an antiexcitotoxic effect of the S-PE-4-yn enantiomer that reduces the frequency of postsynaptic currents and enhances the inhibitory postsynaptic transmission dependent on the co-culture condition.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20422280     DOI: 10.1007/s10571-010-9518-8

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  42 in total

1.  Temporospatial coupling of networked synaptic activation of AMPA-type glutamate receptor channels and calcium transients in cultured motoneurons.

Authors:  K Jahn; J Grosskreutz; K Haastert; E Ziegler; F Schlesinger; C Grothe; R Dengler; J Bufler
Journal:  Neuroscience       Date:  2006-09-01       Impact factor: 3.590

2.  Valproic acid treatment in six patients with spinal muscular atrophy.

Authors:  L-K Tsai; C-C Yang; W-L Hwu; H Li
Journal:  Eur J Neurol       Date:  2007-12       Impact factor: 6.089

3.  Novel valproic acid derivatives with potent differentiation-inducing activity in myeloid leukemia cells.

Authors:  Hedwig Deubzer; Barbara Busche; Gabi Rönndahl; Daniel Eikel; Martin Michaelis; Jindrich Cinatl; Sandra Schulze; Heinz Nau; Olaf Witt
Journal:  Leuk Res       Date:  2006-02-28       Impact factor: 3.156

Review 4.  Crosstalk between astrocytes and motor neurons: what is the message?

Authors:  L Van Den Bosch; W Robberecht
Journal:  Exp Neurol       Date:  2008-01-26       Impact factor: 5.330

5.  Glial cells potentiate kainate-induced neuronal death in a motoneuron-enriched spinal coculture system.

Authors:  W Vandenberghe; L Van Den Bosch; W Robberecht
Journal:  Brain Res       Date:  1998-10-05       Impact factor: 3.252

6.  Additive neuroprotective effects of a histone deacetylase inhibitor and a catalytic antioxidant in a transgenic mouse model of amyotrophic lateral sclerosis.

Authors:  Susanne Petri; Mahmoud Kiaei; Khatuna Kipiani; Junyu Chen; Noel Y Calingasan; John P Crow; M Flint Beal
Journal:  Neurobiol Dis       Date:  2005-11-11       Impact factor: 5.996

7.  Pentyl-4-yn-valproic acid enhances both spatial and avoidance learning, and attenuates age-related NCAM-mediated neuroplastic decline within the rat medial temporal lobe.

Authors:  K J Murphy; G B Fox; A G Foley; H C Gallagher; A O'Connell; A M Griffin; H Nau; C M Regan
Journal:  J Neurochem       Date:  2001-08       Impact factor: 5.372

8.  Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons.

Authors:  Makiko Nagai; Diane B Re; Tetsuya Nagata; Alcmène Chalazonitis; Thomas M Jessell; Hynek Wichterle; Serge Przedborski
Journal:  Nat Neurosci       Date:  2007-04-15       Impact factor: 24.884

Review 9.  Evolving anticancer drug valproic acid: insights into the mechanism and clinical studies.

Authors:  Roman A Blaheta; Martin Michaelis; Pablo Hernáiz Driever; Jindrich Cinatl
Journal:  Med Res Rev       Date:  2005-07       Impact factor: 12.944

10.  Sodium valproate exerts neuroprotective effects in vivo through CREB-binding protein-dependent mechanisms but does not improve survival in an amyotrophic lateral sclerosis mouse model.

Authors:  Caroline Rouaux; Irina Panteleeva; Frédérique René; Jose-Luis Gonzalez de Aguilar; Andoni Echaniz-Laguna; Luc Dupuis; Yannick Menger; Anne-Laurence Boutillier; Jean-Philippe Loeffler
Journal:  J Neurosci       Date:  2007-05-23       Impact factor: 6.167

View more
  3 in total

Review 1.  Advances in cellular models to explore the pathophysiology of amyotrophic lateral sclerosis.

Authors:  C Veyrat-Durebex; P Corcia; A Dangoumau; F Laumonnier; E Piver; P H Gordon; C R Andres; P Vourc'h; H Blasco
Journal:  Mol Neurobiol       Date:  2013-11-07       Impact factor: 5.590

Review 2.  Therapeutic neuroprotective agents for amyotrophic lateral sclerosis.

Authors:  Rachna S Pandya; Haining Zhu; Wei Li; Robert Bowser; Robert M Friedlander; Xin Wang
Journal:  Cell Mol Life Sci       Date:  2013-07-18       Impact factor: 9.261

Review 3.  Current Therapy of Drugs in Amyotrophic Lateral Sclerosis.

Authors:  Haiyan Lu; Wei Dong Le; Ya-Ying Xie; Xiao-Ping Wang
Journal:  Curr Neuropharmacol       Date:  2016       Impact factor: 7.363

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.